5 Go-to-Market Lessons from AdviNOW Medical’s Journey to Revolutionize Healthcare

5 Go-to-Market Lessons from AdviNOW Medical’s Journey to Revolutionize Healthcare

Sometimes the biggest opportunities aren’t found through market research, but through forensic analysis of broken systems. In a recent episode of Category Visionaries, James Bates, founder of AdviNOW Medical, revealed how a Six Sigma cost analysis of medical clinics uncovered systemic inefficiencies that would become the foundation of a healthcare AI company.

1. Use Engineering Principles to Find Hidden Market Opportunities

When James started investigating medical practices during a non-compete period, he didn’t rely on traditional market research. Instead, he applied Six Sigma cost analysis to understand why these businesses struggled. “I cost every single movement in the clinic from the time the patient goes in. What does a front desk do? Do they have to stand up three times? Do they go to the printer?” This granular analysis revealed that “two thirds of a physician’s time was spent doing activities that there was no regulatory reason for them to do.”

2. Understand the Real Pain Points Before Building Solutions

Through his analysis, James discovered that medical practices were barely profitable despite operating in one of America’s largest industries. “Most people think, oh, doctors, everything associated with medicine, a third of our economy, that must be everyone’s rich. But the medical practice businesses, they don’t make money. We’re talking low, single digit EBITDA.” This insight helped shape a solution that would address both efficiency and profitability challenges.

3. Map Stakeholder Incentives Before Disrupting Industries

Perhaps James’ most crucial discovery was about healthcare’s incentive structures. “Nobody actually wants to reduce the cost of healthcare,” he revealed, explaining how insurance companies are actually incentivized to increase revenue rather than efficiency. This led to a key GTM strategy: position the solution as a win for all stakeholders. “AdviNOW saves you and it saves the patient. Nobody loses. And so all the constituencies can win when AdviNOW is adopted.”

4. Choose Strategic Capital Over Traditional VC Funding

Instead of pursuing traditional Silicon Valley VC money, AdviNOW sought strategic investors who brought industry expertise and distribution channels. “I also have companies like Global Med, which is a strategic investor. They sell medical equipment, and bundling AdviNOW software with their medical equipment is a strategy that they were considering.” This approach helped create natural go-to-market partnerships.

5. Target the Most Acute Pain Points First

AdviNOW’s initial focus on urgent care and primary care clinics was strategic – these facilities “suffer the most with the overhead burden and the low profitability.” By proving their model where the pain was most acute, they created compelling case studies for larger health systems.

For B2B founders targeting regulated industries, these lessons highlight the importance of deep system analysis over surface-level market research. Understanding and aligning stakeholder incentives is crucial for driving adoption, while strategic partnerships can provide more value than pure financial investments.

James’ journey shows that sometimes the best GTM strategy isn’t about disrupting an industry, but about creating alignment between existing stakeholders. As he puts it, “I’m looking forward to a world where healthcare is not a mystery. Healthcare is solved.” His approach offers a blueprint for founders tackling complex, regulated markets where simple disruption isn’t enough – you need to create value for every stakeholder in the ecosystem.